Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Papagelopoulos, E. Galanis, F. Sim, K. Unni (1999)
Clinicopathologic features, diagnosis, and treatment of osteoblastoma.Orthopedics, 22 2
H. Nadel (2010)
Pediatric bone scintigraphy update.Seminars in nuclear medicine, 40 1
J. Obert, L. Vercellino, A. Gucht, C. Margerie-Mellon, E. Bugnet, S. Chevret, G. Lorillon, A. Tazi (2017)
18F-fluorodeoxyglucose positron emission tomography-computed tomography in the management of adult multisystem Langerhans cell histiocytosisEuropean Journal of Nuclear Medicine and Molecular Imaging, 44
Toshihiko Hara, Keizo Inagaki, Noboru Kosaka, Toyohiko Morita (2000)
Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 41 9
W. Brenner, J. Eary, Wi-Sub Hwang, C. Vernon, E. Conrad (2006)
Risk assessment in liposarcoma patients based on FDG PET imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 33
A. Beer, R. Haubner, M. Sarbia, Michael Goebel, S. Luderschmidt, A. Grosu, O. Schnell, M. Niemeyer, H. Kessler, H. Wester, W. Weber, M. Schwaiger (2006)
Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin αvβ3 Expression in ManClinical Cancer Research, 12
JH Thrall (1976)
1CRC Crit Rev Clin Radiol Nucl Med., 8
J. Birchall, K. Blackband, B. Freeman, R. Ganatra, M. O’Leary, A. Perkins (2004)
Precise localisation of osteoblastoma with SPET/CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 31
F. Feldman, R. Heertum, C. Saxena, M. Parisien (2005)
18FDG-PET applications for cartilage neoplasmsSkeletal Radiology, 34
J. Thrall (1976)
Technetium-99m labeled agents for skeletal imaging.CRC critical reviews in clinical radiology and nuclear medicine, 8 1
Y. Choi, J. Kim, S. Yang (2014)
PET/CT in Benign and Malignant Musculoskeletal Tumors and Tumor-Like ConditionsSeminars in Musculoskeletal Radiology, 18
B. Jamet, T. Carlier, L. Campion, E. Bompas, S. Girault, Fanny Borrely, L. Ferrer, Maxime Rousseau, Y. Venel, F. Kraeber-Bodéré, C. Rousseau (2017)
Initial FDG-PET/CT predicts survival in adults Ewing sarcoma family of tumorsOncotarget, 8
T. Kubo, T. Furuta, M. Johan, M. Ochi (2016)
Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis.European journal of cancer, 58
A. Imperiale, T. Moser, D. Ben-Sellem, L. Mertz, A. Gangi, A. Constantinesco (2009)
Osteoblastoma and osteoid osteoma: morphofunctional characterization by MRI and dynamic F-18 FDG PET/CT before and after radiofrequency ablation.Clinical nuclear medicine, 34 3
Chalinee Monsereenusorn, C. Rodríguez-Galindo (2015)
Clinical Characteristics and Treatment of Langerhans Cell Histiocytosis.Hematology/oncology clinics of North America, 29 5
S. Punt, J. Eary, J. O'Sullivan, E. Conrad (2009)
Fluorodeoxyglucose positron emission tomography in leiomyosarcoma: imaging characteristicsNuclear Medicine Communications, 30
E. Eisenhauer, P. Therasse, J. Bogaerts, L. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, Lawrence Rubinstein, L. Shankar, L. Dodd, Robert Kaplan, D. Lacombe, J. Verweij (2009)
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).European journal of cancer, 45 2
Y-J Li, Y. Dai, Y.S. Cheng, W-B Zhang, C. Tu (2016)
Positron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: A meta-analysis.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 42 8
Joe Lee, B. Hoang, A. Ziogas, J. Zell (2010)
Analysis of prognostic factors in Ewing sarcoma using a population‐based cancer registryCancer, 116
B. Rubin, C. Fletcher (2000)
Myxoid leiomyosarcoma of soft tissue, an underrecognized variant.The American journal of surgical pathology, 24 7
M. Davis, A. Jones (1976)
Comparison of 99mTc-labeled phosphate and phosphonate agents for skeletal imaging.Seminars in nuclear medicine, 6 1
R. Hawkins, Yong-Seok Choi, Sung-Cheng Huang, C. Hoh, M. Dahlbom, C. Schiepers, N. Satyamurthy, J. Barrio, M. Phelps (1992)
Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 33 5
H. Mammar, K. Kerrou, V. Nataf, D. Pontvert, S. Clemenceau, G. Lot, B. George, M. Polivka, K. Mokhtari, R. Ferrand, L. Feuvret, J. Habrand, J. Pouysségur, N. Mazure, J. Talbot (2012)
Positron emission tomography/computed tomography imaging of residual skull base chordoma before radiotherapy using fluoromisonidazole and fluorodeoxyglucose: potential consequences for dose painting.International journal of radiation oncology, biology, physics, 84 3
K. Xarchas, G. Kyriakopoulos, Spyros Manthas, L. Oikonomou (2017)
Hallux Osteoid Osteoma: A Case Report and Literature ReviewThe Open Orthopaedics Journal, 11
D. Harrison, M. Parisi, B. Shulkin (2017)
The Role of 18F-FDG-PET/CT in Pediatric Sarcoma.Seminars in nuclear medicine, 47 3
E. Satter, W. High (2008)
Langerhans cell histiocytosis: a case report and summary of the current recommendations of the Histiocyte Society.Dermatology online journal, 14 3
F. Ricard, Sébastien Cimarelli, E. Deshayes, T. Mognetti, P. Thiesse, F. Giammarile (2011)
Additional Benefit of F-18 FDG PET/CT in the Staging and Follow-up of Pediatric RhabdomyosarcomaClinical Nuclear Medicine, 36
S. Oueriagli, I. Ghfir, H. Guerrouj, N. Raïs (2016)
What role for radiobiphosphonates bone scintigraphy in the monitoring of an unusual bone giant cell tumor: a case report and literature review.American journal of nuclear medicine and molecular imaging, 6 2
P. Jager, W. Vaalburg, J. Pruim, E. Vries, K. Langen, D. Piers (2001)
Radiolabeled amino acids: basic aspects and clinical applications in oncology.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 42 3
E. Satter, W. High (2008)
Langerhans Cell Histiocytosis: A Review of the Current Recommendations of the Histiocyte SocietyPediatric Dermatology, 25
Giudici Ma, R. Moser, M. Kransdorf (1993)
Cartilaginous bone tumors.Radiologic clinics of North America, 31 2
M. McCarville, Ryan Christie, N. Daw, S. Spunt, S. Kaste (2005)
PET/CT in the evaluation of childhood sarcomas.AJR. American journal of roentgenology, 184 4
D. Lucas, K. Unni, R. McLeod, M. O’Connor, F. Sim (1994)
Osteoblastoma: clinicopathologic study of 306 cases.Human pathology, 25 2
N. Miyazawa, K. Ishigame, S. Kato, Y. Satoh, T. Shinohara (2008)
Thoracic chordoma: review and role of FDG-PET.Journal of neurosurgical sciences, 52 4
G. González, J. Abril, I. Mediero, T. Epeldegui (1996)
Osteoid osteoma with a multicentric nidusInternational Orthopaedics, 20
Choichi Horiuchi, T. Taguchi, Takafumi Yoshida, G. Nishimura, M. Kawakami, Y. Tanigaki, H. Matsuda, Y. Mikami, T. Oka, Tomio Inoue, M. Tsukuda (2008)
Early assessment of clinical response to concurrent chemoradiotherapy in head and neck carcinoma using fluoro-2-deoxy-d-glucose positron emission tomography.Auris, nasus, larynx, 35 1
N. Esiashvili, M. Goodman, R. Marcus (2008)
Changes in Incidence and Survival of Ewing Sarcoma Patients Over the Past 3 Decades: Surveillance Epidemiology and End Results DataJournal of Pediatric Hematology/Oncology, 30
S. Baum, M. Frühwald, K. Rahbar, J. Wessling, O. Schober, M. Weckesser (2011)
Contribution of PET/CT to Prediction of Outcome in Children and Young Adults with RhabdomyosarcomaThe Journal of Nuclear Medicine, 52
J. García, A. Castañeda, A. Madrid, P. Bassa, M. Soler, E. Riera (2017)
Estadificación y seguimiento terapéutico en un paciente con sarcoma de Ewing mediante PET/TC con 18F-FDGRevista Española de Medicina Nuclear e Imagen Molecular
R. Haupt, M. Minkov, I. Astigarraga, E. Schäfer, V. Nanduri, R. Jubran, R. Egeler, G. Janka, D. Mićić, C. Rodríguez-Galindo, S. Gool, J. Visser, S. Weitzman, J. Donadieu (2012)
Langerhans Cell Histiocytosis (LCH): Guidelines for Diagnosis, Clinical Work-Up, and Treatment for Patients Till the Age of 18 YearsPediatric Blood & Cancer, 60
H. Schirrmeister, A. Guhlmann, J. Kotzerke, C. Santjohanser, T. Kühn, R. Kreienberg, Peter Messer, K. Nüssle, K. Elsner, G. Glatting, Harald Träger, B. Neumaier, C. Diederichs, S. Reske (1999)
Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 8
Ji-gang Yang, I. Codreanu, Sabah Servaes, H. Zhuang (2012)
Earlier detection of bone metastases from pleomorphic liposarcoma in a pediatric patient by FDG PET/CT than planar 99mTc MDP bone scan.Clinical nuclear medicine, 37 5
Hisataka Kobayashi, Y. Kotoura, M. Hosono, H. Sakahara, M. Hosono, Z. Yao, T. Tsuboyama, T. Yamamuro, K. Endo, J. Konishi (1995)
Diagnostic Value of Tc‐99m (V) DMSA for Chondrogenic Tumors With Positive Tc‐99m HMDP Uptake on Bone ScintigraphyClinical Nuclear Medicine, 20
Hee Park, S. Kwon, Sang-Geon Cho, Jahae Kim, Ho-Chun Song, S. Kim, Yeon Yoon, Jin Park (2016)
Giant Cell Tumor with Secondary Aneurysmal Bone Cyst Shows Heterogeneous Metabolic Pattern on 18F-FDG PET/CT: A Case ReportNuclear Medicine and Molecular Imaging, 50
Hayato Nose, H. Otsuka, Y. Otomi, Kaori Terazawa, S. Takao, S. Iwamoto, M. Harada (2013)
Correlations between F-18 FDG PET/CT and pathological findings in soft tissue lesions.The journal of medical investigation : JMI, 60 3-4
M. Charest, M. Hickeson, R. Lisbona, J. Novales-Diaz, V. Derbekyan, R. Turcotte (2009)
FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 casesEuropean Journal of Nuclear Medicine and Molecular Imaging, 36
M. Wülling, G. Delling, E. Kaiser (2003)
The origin of the neoplastic stromal cell in giant cell tumor of bone.Human pathology, 34 10
F. Frassica, B. Sanjay, K. Unni, R. McLeod, F. Sim (1993)
Benign giant cell tumor.Orthopedics, 16 10
J. García, A. Castañeda, A. Madrid, P. Bassa, M. Soler, E. Riera (2017)
Staging and follow-up of a Ewing sarcoma patient using 18F-FDG PET/CT.Revista espanola de medicina nuclear e imagen molecular, 37 6
Manabu Hoshi, N. Oebisu, J. Takada, K. Wakasa, Hiroaki Nakamura (2013)
A Case of Dedifferentiated Liposarcoma Showing a Biphasic Pattern on 2-Deoxy-2-F18-Fluoro-D-Glucose Positron Emission Tomography/Computed TomographyRare Tumors, 5
E. Staals, P. Bacchini, M. Mercuri, F. Bertoni (2007)
Dedifferentiated chondrosarcomas arising in preexisting osteochondromas.The Journal of bone and joint surgery. American volume, 89 5
Venkatesh Kashi, M. Hatley, R. Galindo (2015)
Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systemsNature Reviews Cancer, 15
A. Mavrogenis, P. Papagelopoulos, P. Soucacos (2008)
Skeletal osteochondromas revisited.Orthopedics, 31 10
K. Andersen, H. Fuglo, S. Rasmussen, M. Petersen, A. Loft (2015)
Volume-Based F-18 FDG PET/CT Imaging Markers Provide Supplemental Prognostic Information to Histologic Grading in Patients With High-Grade Bone or Soft Tissue SarcomaMedicine, 94
Yun Dong, Xuemei Zhang, Shaoyan Wang, Suyun Chen, Chao Ma (2015)
18F-FDG PET/CT is useful in initial staging, restaging for pediatric rhabdomyosarcoma.The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 61 4
Frederick Grant (2014)
¹⁸F-fluoride PET and PET/CT in children and young adults.PET clinics, 9 3
H. Yamamoto, S. Sugimoto, K. Miyoshi, H. Yamamoto, J. Soh, M. Yamane, S. Toyooka, T. Oto, S. Miyoshi (2014)
[The role of 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) in liposarcoma of the chest wall].Kyobu geka. The Japanese journal of thoracic surgery, 67 1
J. Infante, R. Lorente, J. Rayo, J. Serrano, M. Domínguez, L. García, M. Moreno (2015)
[Use of radioguided surgery in the surgical treatment of osteoid osteoma].Revista espanola de medicina nuclear e imagen molecular, 34 4
Ö. Berlin, L. Angervall, L. Kindblom, I. Berlin, B. Stener (1987)
Primary leiomyosarcoma of boneSkeletal Radiology, 16
William Raynor, S. Houshmand, S. Gholami, S. Emamzadehfard, C. Rajapakse, B. Blomberg, T. Werner, P. Høilund-Carlsen, J. Baker, A. Alavi (2016)
Evolving Role of Molecular Imaging with 18F-Sodium Fluoride PET as a Biomarker for Calcium MetabolismCurrent Osteoporosis Reports, 14
U. Salem, B. Amini, H. Chuang, N. Daw, Wei Wei, T. Haygood, J. Madewell, C. Costelloe (2017)
18F-FDG PET/CT as an Indicator of Survival in Ewing Sarcoma of BoneJournal of Cancer, 8
I. Sultan, I. Qaddoumi, S. Yaser, C. Rodríguez-Galindo, A. Ferrari (2009)
Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 20
DD Moore (2014)
65Cancer Treat Res., 162
M. Manus, R. Hicks, J. Matthews, A. McKenzie, D. Rischin, E. Salminen, D. Ball (2003)
Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 7
K. Boye, N. Jebsen, O. Zaikova, H. Knobel, A. Løndalen, C. Trovik, O. Monge, K. Hall (2017)
Denosumab in patients with giant-cell tumor of bone in Norway: results from a nationwide cohortActa Oncologica, 56
M. Ishibashi, Y. Tanabe, S. Fujii, T. Ogawa (2016)
Pictorial review of 18F-FDG PET/CT findings in musculoskeletal lesionsAnnals of Nuclear Medicine, 31
M. Ochoa-Figueroa, E. Martínez-Gimeno, A. Allende-Riera, D. Cabello-García, J. Muñoz-Iglesias, C. Cárdenas-Negro (2012)
Role of 18F-FDG PET-CT in the study of sacrococcygeal chordoma.Revista espanola de medicina nuclear e imagen molecular, 31 6
C. Costelloe, H. Chuang, J. Madewell (2014)
FDG PET/CT of primary bone tumors.AJR. American journal of roentgenology, 202 6
A. Buck, K. Herrmann, C. Büschenfelde, M. Juweid, M. Bischoff, G. Glatting, G. Weirich, P. Möller, H. Wester, K. Scheidhauer, T. Dechow, C. Peschel, M. Schwaiger, S. Reske (2008)
Imaging Bone and Soft Tissue Tumors with the Proliferation Marker [18F]FluorodeoxythymidineClinical Cancer Research, 14
Y. Jeong, M. Sohn, S. Lim, D. Kim, Hwan-Jeong Jeong, K. Jang, C. Yim (2011)
Osteoblastoma in the nasal cavity: F-18 FDG PET/CT and Tc-99m MDP 3-phase bone scan findings with pathologic correlation.Clinical nuclear medicine, 36 3
R. Rakheja, W. Makis, S. Skamene, A. Nahal, F. Brimo, L. Azoulay, Jonathan Assayag, R. Turcotte, M. Hickeson (2012)
Correlating metabolic activity on 18F-FDG PET/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients.AJR. American journal of roentgenology, 198 6
R. Parghane, S. Basu (2017)
Dual-time point 18F-FDG-PET and PET/CT for Differentiating Benign From Malignant Musculoskeletal Lesions: Opportunities and Limitations.Seminars in nuclear medicine, 47 4
J. Krämer, Raphael Gübitz, L. Beck, W. Heindel, V. Vieth (2014)
Bildgebende Diagnostik der KnochensarkomeDer Unfallchirurg, 117
W. O'Connor, M. Quintana, S. Smith, M. Willis, J. Renner (2014)
The hypermetabolic giant: 18F-FDG avid giant cell tumor identified on PET-CT.Journal of radiology case reports, 8 6
T. Pansuriya, H. Kroon, J. Bovée (2010)
Enchondromatosis: insights on the different subtypes.International journal of clinical and experimental pathology, 3 6
Ö. Kasalak, A. Glaudemans, J. Overbosch, P. Jutte, T. Kwee (2017)
Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma?Skeletal Radiology, 47
R. Hicks, G. Toner, P. Choong (2005)
Clinical applications of molecular imaging in sarcoma evaluationCancer Imaging, 5
N. Laurence, M. Epelman, R. Markowitz, C. Jaimes, D. Jaramillo, N. Chauvin (2012)
Osteoid osteomas: a pain in the night diagnosisPediatric Radiology, 42
M. McMaster, A. Goldstein, C. Bromley, N. Ishibe, D. Parry (2004)
Chordoma: incidence and survival patterns in the United States, 1973–1995Cancer Causes & Control, 12
J. Sproule, F. Khan, E. Fogarty (2004)
Osteoid osteoma: painful enlargement of the second toeArchives of Orthopaedic and Trauma Surgery, 124
C. Hoh, R. Hawkins, M. Dahlbom, J. Glaspy, L. Seeger, Yong-Seok Choi, C. Schiepers, Sung-Cheng Huang, N. Satyamurthy, J. Barrio, M. Phelps (1993)
Whole body skeletal imaging with [18F]fluoride ion and PET.Journal of computer assisted tomography, 17 1
S. Sheikhbahaei, C. Marcus, N. Hafezi-Nejad, M. Taghipour, R. Subramaniam (2015)
Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.PET clinics, 10 3
Kusai Al-Muqbel, Mamoon Al-Omari, Z. Audat, M. Alqudah (2013)
Osteoblastoma Is a Metabolically Active Benign Bone Tumor on 18F-FDG PET ImagingThe Journal of Nuclear Medicine Technology, 41
J. Hwang, I. Lim, Chang-Bae Kong, D. Jeon, B. Byun, Byung Kim, C. Choi, Sang-Moo Lim (2016)
Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing SarcomaPLoS ONE, 11
R. Jesus-Garcia, Akemi Osawa, R. Filippi, D. Viola, M. Korukian, Guilherme Neto, J. Wagner (2016)
Is PET–CT an accurate method for the differential diagnosis between chondroma and chondrosarcoma?SpringerPlus, 5
N. Quartuccio, J. Fox, D. Kuk, L. Wexler, S. Baldari, A. Cistaro, H. Schöder (2015)
Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.AJR. American journal of roentgenology, 204 1
H. Wieder, K. Pomykala, M. Benz, A. Buck, K. Herrmann (2014)
PET Tracers in Musculoskeletal Disease beyond FDGSeminars in Musculoskeletal Radiology, 18
H. Goo, D. Yang, Y. Ra, J. Song, H. Im, J. Seo, T. Ghim, H. Moon (2006)
Whole-body MRI of Langerhans cell histiocytosis: comparison with radiography and bone scintigraphyPediatric Radiology, 36
A. Iagaru, M. Goris (2008)
Rhabdomyosarcoma diffusely metastatic to the bone marrow: suspicious findings on 99mTc-MDP bone scintigraphy confirmed by 18F-18 FDG PET/CT and bone marrow biopsyEuropean Journal of Nuclear Medicine and Molecular Imaging, 35
E. Palmerini, M. Colangeli, C. Nanni, S. Fanti, E. Marchesi, A. Paioli, P. Picci, S. Cambioli, D. Donati, L. Cevolani, M. Paolis, M. Gambarotti, S. Ferrari (2016)
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomasEuropean Journal of Nuclear Medicine and Molecular Imaging, 44
Caitlin Hurley, M. McCarville, B. Shulkin, S. Mao, Jianrong Wu, F. Navid, N. Daw, A. Pappo, M. Bishop (2016)
Comparison of 18F‐FDG‐PET‐CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent OsteosarcomaPediatric Blood & Cancer, 63
P. Sharma, A. Mukherjee, S. Karunanithi, J. Nadarajah, S. Gamanagatti, S. Khan, C. Bal, Rakesh Kumar (2014)
99mTc-Methylene diphosphonate SPECT/CT as the one-stop imaging modality for the diagnosis of osteoid osteomaNuclear Medicine Communications, 35
W. Brenner, E. Conrad, J. Eary (2004)
FDG PET imaging for grading and prediction of outcome in chondrosarcoma patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 31
H. Douis, A. Saifuddin (2012)
The imaging of cartilaginous bone tumours. I. Benign lesionsSkeletal Radiology, 41
RA Hawkins (1992)
633J Nucl Med, 33
H Schirrmeister (1999)
1623J Nucl Med., 40
U. Tateishi, A. Hosono, A. Makimoto, Y. Nakamoto, T. Kaneta, H. Fukuda, K. Murakami, T. Terauchi, Tsuyoshi Suga, Tomio Inoue, Edmund Kim (2009)
Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcomaAnnals of Nuclear Medicine, 23
P. Therasse, S. Arbuck, E. Eisenhauer, J. Wanders, R. Kaplan, L. Rubinstein, J. Verweij, M. Glabbeke, A. Oosterom, M. Christian, S. Gwyther (2000)
New guidelines to evaluate the response to treatment in solid tumorsBreast Cancer, 12
P. Lapa, M. Marques, G. Costa, A. Iagaru, J. Lima (2017)
Assessment of skeletal tumour burden on 18F-NaF PET/CT using a new quantitative methodNuclear Medicine Communications, 38
H. Schirrmeister, A. Guhlmann, K. Elsner, J. Kotzerke, G. Glatting, Mary Rentschler, B. Neumaier, Harald Trager, Naumann Karin, S. Reske (1999)
Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 40 10
J. Salotti, V. Nanduri, M. Pearce, L. Parker, R. Lynn, K. Windebank (2008)
Incidence and clinical features of Langerhans cell histiocytosis in the UK and IrelandArchives of Disease in Childhood, 94
Bryan Le, B. Nguyen (2014)
Ollier disease with digital enchondromatosis: anatomic and functional imaging.Clinical nuclear medicine, 39 8
Soon-Ah Park, Hun Kim (2008)
F-18 FDG PET/CT evaluation of sacrococcygeal chordoma.Clinical nuclear medicine, 33 12
Curr Radiol Rep (2018) 6:29 https://doi.org/10.1007/s40134-018-0290-8 GERIATRICS (G GUGLIELMI, SECTION EDITOR) PET/CT and Bone Scintigraphy: Metabolic Results in Musculoskeletal Lesions 1 2 1 3 • • • • Rosj Gallicchio Anna Nardelli Piernicola Pedicini Giuseppe Guglielmi Giovanni Storto Springer Science+Business Media, LLC, part of Springer Nature 2018 Abstract Additionally, the metabolic assessment has been demon- Purpose This review aimed to provide an overview on strated useful for predicting surgical response and patients’ findings from metabolic imaging modalities such as bone outcome. scintigraphy and positron emission tomography–computed tomography (PET/CT) in musculoskeletal lesions. It is Keywords PET/CT Bone scintigraphy Musculoskeletal conceivable that methods assessing metabolism of bone neoplasms Metabolic findings Diagnosis and follow-up tumors, combined with the morphological assessment, could enhance the possibility for a personalized therapy with particular emphasis to malignant neoplasms. Introduction Recent Findings The assessment of bone tumors by con- ventional scintigaphic and morphological imaging has been The assessment of disorders affecting skeleton and muscles recently integrated with the morpho-metabolic appraisal relies mainly on morphological imaging. In fact, anatomic obtained by PET/CT systems. Increasing availability of this imaging procedures including ultrasound, conventional diagnostic modality has been shown to stratify properly the radiography, computed tomography
Current Radiology Reports – Springer Journals
Published: Jul 3, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.